New Delhi, February 26, 2026: In a significant step toward strengthening India’s deep-tech healthcare ecosystem, the Technology Development Board (TDB) under the Department of Science & Technology has signed an agreement with Ayukriyam Innovations Pvt. Ltd. to support the development and commercialization of “Autoscope,” an AI-driven whole slide imaging diagnostic system.
Driving Indigenous Medical Technology
The initiative aligns with the Government of India’s broader push for technological self-reliance in healthcare and promotion of indigenous research-based innovation. The Autoscope platform is designed as a fully automated whole slide imaging system integrated with artificial intelligence-based diagnostic capabilities.
Ayukriyam Innovations is a deep-tech spin-off from the Molecular Imaging & Diagnostics Lab at the Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi. The startup focuses on advanced microscopy systems enhanced with AI to enable rapid and reliable diagnosis, particularly for infectious diseases.
The company aims to make diagnostic systems more accessible, especially in resource-constrained settings where pathology infrastructure often faces limitations.
Addressing Critical Gaps in Pathology
The Autoscope system is being developed to address gaps in India’s pathology infrastructure. It offers high-throughput, standardized, and scalable workflows, ensuring improved efficiency and consistency in diagnostic processes.
By leveraging indigenous research and AI-enabled image analytics, the technology is expected to enhance diagnostic accuracy while reducing dependence on imported high-end imaging systems. This aligns with the vision of Aatmanirbhar Bharat in the medical devices sector.
Officials noted that indigenous whole slide imaging systems could significantly lower costs and improve availability in district hospitals, medical colleges, and diagnostic centres.
TDB’s Financial Support
The sanctioned assistance from TDB will help establish a dedicated manufacturing facility for Autoscope. It will also support the production of multiple product batches and comprehensive field performance evaluations before commercial rollout.
Shri Rajesh Kumar Pathak, Secretary, TDB, said indigenous development of advanced diagnostic platforms integrating imaging and artificial intelligence is crucial for strengthening India’s healthcare infrastructure. He emphasised that TDB’s support aims to accelerate the transition from laboratory innovation to market-ready products.
The funding will facilitate commercialization of the deep-tech platform and help build a sustainable domestic ecosystem for advanced diagnostic technologies.
Boost for Affordable Healthcare
Promoters of Ayukriyam Innovations expressed appreciation for the institutional support, stating that it would fast-track manufacturing readiness and field deployment of Autoscope. The platform is expected to improve access to reliable, technology-driven diagnostics across the country.
The project reinforces TDB’s mandate to provide financial assistance for commercialization of indigenous technologies developed through in-house research and institutional collaborations. It also underscores the government’s continued focus on innovation-led growth in critical sectors such as healthcare and medical devices.
As India continues to scale its startup and research ecosystem, initiatives like Autoscope highlight how deep-tech enterprises can contribute to strengthening public health systems while reducing import dependence in advanced medical technologies.
